Compound class:
Synthetic organic
Comment: Firzacorvir is an antiviral agent. It acts as an inhibitor of hepatitis B virus (HBV) core protein (a.k.a. capsid assembly modulator or core protein allosteric modulator [1]), and via this mechanism it disrupts HBV replication. This chemical structure was obtained from INN proposed list 124 (December 2020).
|
|
Bioactivity Comments |
We have been unable to find published data that confirms firzacorvir's proposed mechanism of action. |